Other languages Walvax Biotechnology Co., Ltd.

Equities

300142

CNE100000WN2

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-14 pm EDT			5-day change	1st Jan Change
14.22 ^CNY	-1.46%		-5.26%	-39.52%

Apr. 02	Walvax Biotechnology's 2023 Profit Falls 42%	MT
Apr. 01	Walvax Biotechnology Scraps Plan to Issue Convertible Bonds	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Walvax Biotechnology's 2023 Profit Falls 42%	Apr. 02
Walvax Biotechnology Co., Ltd. Proposes Cash Profit Distribution for 2023	Apr. 01
Walvax Biotechnology Scraps Plan to Issue Convertible Bonds	Apr. 01
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26
Walvax Biotechnology Sees Up to 45% Drop in 2023 Profit	Jan. 26
Chinese Shares End Mixed as Stimulus Hopes Fade; Walvax Falls 6% on Downbeat Profit Outlook	Jan. 26
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China	Jan. 10
Lanvin Group Chief Executive Joann Cheng Steps Down	Dec. 08
Walvax Biotechnology Registers Pneumonia Vaccines in Philippines	Nov. 08
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25
Walvax Biotechnology's Unit Gets License to Market Pneumonia Vaccine in Indonesia; Shares Up 3%	23-10-24
Walvax Biotechnology Unit Gets Nod to Carry Out Vaccine's Phase III Trial in Indonesia	23-09-20
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25
Walvax Biotechnology's COVID-19 Vaccine Clinical Trial Results Show Efficacy, Safety	23-07-11
Walvax Biotechnology Chairman, Affiliates Complete Purchase of 101 Million Yuan Shares	23-06-26
Walvax Biotechnology Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 11, 2023	23-05-05
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24
Walvax Biotechnology Co., Ltd. Approves Cash Dividend for 2022	23-04-21
Walvax Biotechnology Co., Ltd. announces an Equity Buyback for 4,000,000 shares, for CNY 200 million.	23-04-05
Walvax Biotechnology Co., Ltd. authorizes a Buyback Plan.	23-04-03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Walvax Biotechnology Co., Ltd.

Equities

300142

CNE100000WN2

Other languages

Filters